InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
4
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Kariv Tomer. Officer active across 3 companies, notably Eloxx Pharmaceuticals, Inc.. Cumulatively, 6 disclosures have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €1.4m. Activity tracked since 13 May 2021. The latest transaction was disclosed on 4 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Kariv Tomer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
5,250 shares0Common StockSEC:0001415889-25-015977:0
3,539 shares100.0% of flowCommon StockSEC:0001209191-22-059051:0
1,280,624 shares@ US$1.35100.0% of flowCommon StockSEC:0001104659-21-067333:0
Canonical exit: 11 Aug 2021 (T+90)
707,868 sharesCommon StockSEC:0000914190-16-000516:0
Canonical exit: 11 Apr 2016 (T+90)
533,208 sharesCommon StockSEC:0000914190-16-000516:1
Canonical exit: 11 Apr 2016 (T+90)
206,986 sharesCommon StockSEC:0000914190-16-000516:2
Canonical exit: 11 Apr 2016 (T+90)
6 of 6 declarations
About Kariv Tomer
Kariv Tomer is a declarant and a director at Arno Therapeutics, Inc, Eloxx Pharmaceuticals, Inc. and Keros Therapeutics, Inc. He has 6 filings in total, and across the sampled recent filings the acquisitions total 2862963 EUR, with no sales, between 2016-01-14 and 2022-11-30.
